Hepatitis: Screening and Testing Methods

The development of serological tests for the identification of a counteracting agent to this newly discovered illness has been spurred by the disclosure of hepatitis infection (HV). Intravenous drug users, hemodialysis patients, hemophiliacs, and blood transfusion recipients are among the groups most seriously at risk of becoming infected with HV. The prevalence of post-transfusion hepatitis has significantly decreased because of screening blood donors for HV antagonists. One of the main problems with HV illness is the progression of chronic hepatitis, which can lead to cirrhosis and hepatocellular cancer in 50–60% of cases

 

    Related Conference of Hepatitis: Screening and Testing Methods

    June 04-05, 2025

    25th International Conference on Gastroenterology and Hepatology

    Edinburgh, Scotland
    July 07-08, 2025

    20th Euro-Global Gastroenterology Conference

    Zurich, Switzerland
    July 28-29, 2025

    31st World Conference on Gastroenterology & Hepatology

    Dubai, UAE
    July 30-31, 2025

    16th International Conference on Liver Diseases & Hepatology

    Paris, France
    July 30-31, 2025

    4th International Conference on Gastroenterology and Liver

    Paris, France
    August 21-22, 2025

    6th Global Summit on Earth Science and Climate Change

    Paris, France
    August 21-22, 2025

    17th World Conference on Gynecology, Obstetrics and Women Health

    London, UK
    August 27-28, 2025

    13th World Gastro Summit

    Paris, France
    September 29-30, 2025

    7th International Conference on Gastroenterology and Liver Diseases

    Paris, France
    October 20-21, 2025

    24th International Conference on Gastroenterology and Digestive Disorders

    Osaka, Japan

    Hepatitis: Screening and Testing Methods Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in